In the past 52-week period, shares of ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) have moved within the range of $24.31 to $41.20. On the stock’s most recent trading day, the company’s shares ended the regular session at $26.84, which is 34.85% lower than its 52-week high.
ACADIA Pharmaceuticals Inc. (ACAD) has demonstrated a 20-day simple moving average (SMA) of -19.48%, and a 50-day SMA of -24.66%. This public company’s current market capitalization stands at $3.35 billion.Analyzing Consensus Estimates, Sales Revenue and Net Income
Understanding Wall Street analyst’s enthusiasm for a particular stock is crucial when considering entering a position. According to the latest data, the consensus recommendation for ACADIA Pharmaceuticals Inc. (ACAD) is Outperform.
When it comes to sales data, public companies usually post revenue and earnings that are either higher or lower than the average Wall Street forecast. In the most recent quarterly financial report, for the quarter ending Sep. 2017, ACADIA Pharmaceuticals Inc. (ACAD) delivered a 11.08% surprise with its net revenue. Sales reached $0.04 billion during the three-month period, compared to the average analyst estimate of $0.03 billion.
Meanwhile, during the same quarter ACADIA Pharmaceuticals Inc. (ACAD) delivered a -15.06% earnings surprise. Net earnings for the quarter were posted at -$0.53 per share, whereas Wall Street had forecast -$0.62 per share.Ownership at ACADIA Pharmaceuticals Inc. (ACAD), According to Most Recent SEC Filings
A public company’s latest 13F filings tell investors important details about institutional ownership. ACADIA Pharmaceuticals Inc. (ACAD) has 0 billion shares outstanding currently, 97.47% of which belong to institutional investors. Those institutional holdings amount to $3.27 billion.
Additionally, according to the most recent 13F filing from ACADIA Pharmaceuticals Inc. (ACAD), there were 33 new positions totaling 1,029,676 shares of the company’s stock. There were 27 sold out positions, on the other hand, totaling 2,382,931 shares.Short, Medium and Long Term Indicators
Examining a stock’s average volume in the short, medium and long term is useful to understand trading activity and investor sentiment. ACADIA Pharmaceuticals Inc. (ACAD) has had a 20-day average volume of 1,822,955 shares, with an average of 80% of short term indicators pointed at Sell.
The stock’s 50-day average volume has been 1,558,342 shares, with an average of 100% of medium term indicators pointing toward Sell. Finally, its 100-day average volume is 1,497,852 shares with 33% of long-term indicators pointing to Sell.